Publikationen, an denen er mitarbeitet María Blanco Prieto (32)

2024

  1. Rna-loaded nanoparticles for the treatment of hematological cancers

    Advanced Drug Delivery Reviews, Vol. 214

2023

  1. Alginate and collagen-based hydrogel: a novel cardiactherapeutic platform for extracellular vesicle delivery

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release, Vol. 361, pp. 130-146

2022

  1. Development of an injectable alginate-collagen hydrogel for cardiac delivery of extracellular vesicles

    International Journal of Pharmaceutics, Vol. 629

  2. Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative study

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 170, pp. 187-196

2021

  1. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

    Acta Biomaterialia, Vol. 126, pp. 394-407

  2. Extracellular vesicle-based therapeutics for heart repair

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-30

2019

  1. Long-term engraftment of human cardiomyocytes combined with biodegradable microparticles induces heart repair

    Journal of Pharmacology and Experimental Therapeutics, Vol. 370, Núm. 3, pp. 761-771

  2. NRG1 PLGA MP locally induce macrophage polarisation toward a regenerative phenotype in the heart after acute myocardial infarction

    Journal of Drug Targeting, Vol. 27, Núm. 5-6, pp. 573-581

2017

  1. Bioresorbable polymers for next-generation cardiac scaffolds

    Bioresorbable Polymers for Biomedical Applications: From Fundamentals to Translational Medicine (Elsevier), pp. 445-467

  2. Cardiac drug delivery

    Drug Delivery: An Integrated Clinical and Engineering Approach (CRC Press), pp. 439-480

  3. Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model

    International Journal of Pharmaceutics, Vol. 523, Núm. 2, pp. 531-533

  4. Hydrogel based approaches for cardiac tissue engineering

    International Journal of Pharmaceutics, Vol. 523, Núm. 2, pp. 454-475

  5. Transplantation of adipose-derived stem cells combined with neuregulin-microparticles promotes efficient cardiac repair in a rat myocardial infarction model

    Journal of Controlled Release, Vol. 249, pp. 23-31

2016

  1. Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion

    Scientific Reports, Vol. 6

  2. PLGA nano- and microparticles for VEGF delivery

    Handbook of Polyester Drug Delivery Systems (Pan Stanford Publishing Pte. Ltd.), pp. 445-478

2015

  1. Growth factor delivery systems for the treatment of cardiovascular diseases

    RSC Smart Materials, Vol. 2015-January, Núm. 10, pp. 74-101

  2. Heart regeneration after myocardial infarction using synthetic biomaterials

    Journal of Controlled Release, Vol. 203, pp. 23-38

  3. Polymeric electrospun scaffolds: Neuregulin encapsulation and biocompatibility studies in a model of myocardial ischemia

    Tissue Engineering - Part A, Vol. 21, Núm. 9-10, pp. 1654-1661

  4. Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts

    Journal of Controlled Release, Vol. 220, pp. 388-396